Evidence map›Paper›PMID 25597877›Full record

ReviewEuropean journal of clinical pharmacology2015

Clinical pharmacology of melatonin in the treatment of tinnitus: a review.

Marco Miroddi, Rocco Bruno, Francesco Galletti, Fabrizio Calapai, Michele Navarra, Sebastiano Gangemi, Gioacchino Calapai

Abstract readReview
PubMed Publisher
In one paragraph

Review in European journal of clinical pharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Guideline
  2. Review
  3. Review
  4. Migrainous Vertigo, Tinnitus, and Ear Symptoms and Alternatives.Otolaryngologic clinics of North America · 2022
    Review
  5. Review of Pharmacotherapy for Tinnitus.Healthcare (Basel, Switzerland) · 2021
    Review
  6. Review
  7. Article
  8. Article
  9. Evidence and evidence gaps in tinnitus therapy.GMS current topics in otorhinolaryngology, head and neck surgery · 2016
    Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Marco MiroddiDepartment of Clinical and Experimental Medicine, University of Messina, Policlinico "G. Martino", Messina, Italy.
Rocco Bruno
Francesco Galletti
Fabrizio Calapai
Michele Navarra
Sebastiano Gangemi
Gioacchino Calapai
University of Messina · ITAzienda Ospedaliera Universitaria Policlinico "G. Martino" · ITNational Research Council · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeWe performed a review with the purpose to summarise, analyse and discuss the evidence provided by clinical studies evaluating effectiveness of melatonin in the cure of tinnitus. Due to the fact that there is no satisfactory treatment for tinnitus, clinical research has explored new therapeutic approaches.

methodsA search of Pubmed, Medline, Embase, Central and Google Scholar was conducted to find trials published prior March 2014 on melatonin in the treatment of tinnitus. Design of the studies, randomization, allocation concealment procedures and diagnostic instruments (scales for tinnitus evaluation) were critical evaluated.

resultsFive clinical studies have been included. Three of them tested effectiveness of melatonin alone, the remaining two along with sulpiride and sulodexide respectively. Considered clinical trials adopted various experimental designs: single arm, randomised placebo-controlled and randomised placebo-controlled followed by crossover. These studies were characterised by several methodological weaknesses.

conclusionConfirmation of melatonin clinical effectiveness in the treatment of tinnitus cannot be given in the light of the biases observed in the considered evidence. Melatonin seems to improve sleep disturbance linked to tinnitus.

Indexed as

Antipsychotic AgentsCentral Nervous System DepressantsDrug Therapy, CombinationGlycosaminoglycansHumansHypolipidemic AgentsMelatoninSulpirideTinnitusAntipsychotic AgentsCentral Nervous System Depressantsglucuronyl glucosamine glycan sulfateGlycosaminoglycansHypolipidemic AgentsMelatoninSulpiride

Identifiers

PMID25597877
OpenAlexW1987911139

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.